| scholarly article | Q13442814 |
| P2093 | author name string | Imhof BA | |
| Gisler RH | |||
| Terpe HJ | |||
| Piali L | |||
| Fichtel A | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| The role of proteolytic enzymes in cancer invasion and metastasis | Q36093846 | ||
| Leukocyte migration and adhesion. | Q40400310 | ||
| Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration | Q41094184 | ||
| Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells | Q41522290 | ||
| Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells | Q41724242 | ||
| Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo | Q42673689 | ||
| Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo | Q67899454 | ||
| Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta | Q67942705 | ||
| YIGSR, a synthetic laminin peptide, inhibits the enhancement by cyclophosphamide of experimental lung metastasis of human fibrosarcoma cells | Q68119770 | ||
| Diminished leukocyte-endothelium interaction in tumor microvessels | Q68223441 | ||
| A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes | Q68804520 | ||
| In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma | Q69789630 | ||
| Regulation of VCAM-1 Expression and Involvement in Cell Adhesion to Murine Microvascular Endothelium | Q72073537 | ||
| Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes) | Q72722889 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| cell adhesion | Q187640 | ||
| P304 | page(s) | 811-816 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma | |
| P478 | volume | 181 |
| Q58566631 | A Task Force Against Local Inflammation and Cancer: Lymphocyte Trafficking to and Within the Skin |
| Q36179662 | Adhesion molecules: opportunities for modulation and a paradigm for novel therapeutic approaches in cancer |
| Q41252667 | An E-selectin-IgG chimera supports sialylated moiety dependent adhesion of colon carcinoma cells under fluid flow |
| Q33630427 | Angiogenesis modulates the tumour immune response |
| Q77584935 | Angiogenesis, a target for tumor therapy |
| Q37148358 | Anti-angiogenesis: making the tumor vulnerable to the immune system |
| Q26852287 | Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells |
| Q92574283 | Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markers |
| Q58122720 | Cancer Immunity and Immune Evasion Mechanisms |
| Q92970937 | Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment |
| Q27012852 | Characteristics of tertiary lymphoid structures in primary cancers |
| Q29994573 | Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy? |
| Q89855404 | Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury |
| Q34093068 | Differentiation therapy of human cancer: basic science and clinical applications |
| Q35747992 | Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668 |
| Q90290795 | Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy |
| Q36114813 | Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma |
| Q74164811 | Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors |
| Q41971783 | Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. |
| Q41873003 | Enhancement of leukocyte adhesion after percutaneous irradiation in rats with hepatocellular carcinoma |
| Q34748661 | Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. |
| Q39406918 | Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer. |
| Q45888601 | Gene therapy for melanoma in humans |
| Q36916400 | Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells |
| Q36568984 | Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy |
| Q39705893 | Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin |
| Q36593767 | Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors |
| Q80351857 | Immune escape mechanism: defective resting and stimulated leukocyte-endothelium interaction in hepatocellular carcinoma of the rat |
| Q41114975 | Immunologic dysfunction in cancer |
| Q41349062 | Immunotherapy I: Cyclosine gene transfer strategies |
| Q33586651 | Impediments to successful immunotherapy |
| Q41861892 | Improving drug uptake and penetration into tumors: current and forthcoming opportunities. |
| Q41922774 | Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses |
| Q37229840 | Intravital imaging of CD8+ T cell function in cancer |
| Q37366828 | Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels |
| Q41140276 | Leukocyte-endothelial adhesion and angiogenesis in tumors |
| Q34224865 | Mechanisms of action of flavopiridol |
| Q28770154 | Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice |
| Q27025036 | Molecular pathways: not a simple tube--the many functions of blood vessels |
| Q42326772 | Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas |
| Q60043738 | Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells |
| Q37983730 | Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy |
| Q40712474 | Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene |
| Q42485476 | Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer |
| Q38928127 | Regulatory circuits of T cell function in cancer |
| Q35799094 | Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. |
| Q74439190 | Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma |
| Q36613961 | Sipuleucel-T (APC8015) for prostate cancer |
| Q34775046 | Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model |
| Q92405303 | T Cell Dysfunction in Cancer Immunity and Immunotherapy |
| Q30408331 | T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins |
| Q38873974 | T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy. |
| Q41125175 | TGF-B2 and soluble p55 TNFR modulate VCAM-1 expression in glioma cells and brain derived endothelial cells |
| Q37063499 | Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress |
| Q57240725 | The Labyrinthine Ways of Cancer Immunotherapy–T Cell, Tumor Cell Encounter: “How Do I Lose Thee? Let Me Count the Ways” |
| Q37516448 | The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment |
| Q95840987 | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies |
| Q58754484 | The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy |
| Q78199146 | Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response |
| Q37360526 | Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. |
| Q37970674 | Tumor evasion from T cell surveillance |
| Q41455911 | Tumor recognition by the cellular immune system: new aspects of tumor immunology. |
| Q40877719 | Tumor vascularity in ovarian cancer: T cells need breathing room |
| Q39793034 | Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy |
| Q42114097 | Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. |
| Q90106416 | VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models |
| Q41636554 | VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma |
| Q37945304 | Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance |
| Q60938392 | Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer |
| Q38207560 | Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis |
| Q26991991 | Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes |
Search more.